Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 3, 2025

November 3, 2025

ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results

GlobeNewswire

November 3, 2025

Picard to Showcase its Total Artificial Heart at the Annual Meeting of the American Heart Association 2025

GlobeNewswire

November 3, 2025

Orchestra BioMed to Host Business Update Call on November 12, 2025

GlobeNewswire

November 3, 2025

Vantive Introduces HomeAdvantage: Digitally-Enabled Home Therapy Ecosystem Designed to Make Home Dialysis Easier to Start, Manage and Sustain

GlobeNewswire

November 3, 2025

Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

GlobeNewswire

November 3, 2025

Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025

GlobeNewswire

November 3, 2025

Opus Genetics Featured on Good Morning America Spotlighting Breakthrough Gene Therapy Restoring Sight in Patients with Inherited Blindness

GlobeNewswire

November 3, 2025

Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer

GlobeNewswire

November 3, 2025

Life Biosciences Appoints Industry Veteran David Guyer, M.D. to Board of Directors

GlobeNewswire

November 3, 2025

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025

GlobeNewswire

November 3, 2025

Aardvark Therapeutics to Present at Upcoming Investor Conferences in November

GlobeNewswire

November 3, 2025

Immutep Receives A$4.6 million R&D Tax Incentive from French Government

GlobeNewswire

November 3, 2025

Kyverna Therapeutics Secures up to $150 Million in Non-Dilutive Financing from Oxford Finance

GlobeNewswire

November 3, 2025

Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025

GlobeNewswire

November 3, 2025

Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results

GlobeNewswire

November 3, 2025

Daré Bioscience to Receive up to $300,000 to Conduct Global Contraceptive Innovation Capabilities Landscape Assessment

GlobeNewswire

November 3, 2025

ORYZON Announces First‑Patient‑In (FPI) in RESTORE Phase Ib Trial of Iadademstat in Sickle Cell Disease

GlobeNewswire

November 3, 2025

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

GlobeNewswire

November 3, 2025

Halberd Corporation Continues Seeking Government Contracts with Scientists at Mississippi State University

GlobeNewswire

November 3, 2025

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire